We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 25.00 | 14.00 | 36.00 | 25.00 | 25.00 | 25.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.86 | 37.33M |
RNS Number:2012I Cambridge Antibody Tech Group PLC 03 February 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Cambridge Antibody Technology 2) Name of director John Aston 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest As in 2 Above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) Computershare Trustees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) As in 2 Above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary Allocation of Partnership and Matching Shares under Inland Revenue Approved Share Incentive Plan 7) Number of shares/amount of stock acquired 642 (consisting of 321 Partnership and 321 Matching Shares) 8) Percentage of issued class 0.0012% 9) Number of shares/amount of stock disposed Nil 10) Percentage of issued class Nil 11) Class of security Ordinary 10 pence shares 12) Price per share #4.67 13) Date of transaction 3 February 2005 14) Date company informed 3 February 2005 15) Total holding following this notification 43,730 16) Total percentage holding of issued class following this notification 0.084% If a director has been granted options by the company please complete the following boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional information This transaction is exempt pursuant to provision 20H of the Model Code of the Listing Rules of the UK Listing Authority 24) Name of contact and telephone number for queries Justin Hoskins : 01223 898589 25) Name and signature of authorised company official responsible for making this notification Diane Mellett Date of Notification 3 February 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Cambridge Antibody Technology 2) Name of director Peter Chambre 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest As in 2 Above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) Computershare Trustees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) As in 2 Above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary Allocation of Partnership and Matching Shares under Inland Revenue Approved Share Incentive Plan 7) Number of shares/amount of stock acquired 642 (consisting of 321 Partnership and 321 Matching Shares) 8) Percentage of issued class 0.0012% 9) Number of shares/amount of stock disposed Nil 10) Percentage of issued class Nil 11) Class of security Ordinary 10 pence shares 12) Price per share #4.67 13) Date of transaction 3 February 2005 14) Date company informed 3 February 2005 15) Total holding following this notification 22,549 16) Total percentage holding of issued class following this notification 0.043% If a director has been granted options by the company please complete the following boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional information This transaction is exempt pursuant to provision 20H of the Model Code of the Listing Rules of the UK Listing Authority 24) Name of contact and telephone number for queries Justin Hoskins : 01223 898589 25) Name and signature of authorised company official responsible for making this notification Diane Mellett Date of Notification 3 February 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Cambridge Antibody Technology 2) Name of director David Glover 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest As in 2 Above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) Computershare Trustees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) As in 2 Above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary Allocation of Partnership and Matching Shares under Inland Revenue Approved Share Incentive Plan 7) Number of shares/amount of stock acquired 642 (consisting of 321 Partnership and 321 Matching Shares) 8) Percentage of issued class 0.0012% 9) Number of shares/amount of stock disposed Nil 10) Percentage of issued class Nil 11) Class of security Ordinary 10 pence shares 12) Price per share #4.67 13) Date of transaction 3 February 2005 14) Date company informed 3 February 2005 15) Total holding following this notification 29,372 16) Total percentage holding of issued class following this notification 0.057% If a director has been granted options by the company please complete the following boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional information This transaction is exempt pursuant to provision 20H of the Model Code of the Listing Rules of the UK Listing Authority 24) Name of contact and telephone number for queries Justin Hoskins : 01223 898589 25) Name and signature of authorised company official responsible for making this notification Diane Mellett Date of Notification 3 February 2005 This information is provided by RNS The company news service from the London Stock Exchange END RDSEAKADEFLSEFE
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions